Doreen Pachow

433 total citations
11 papers, 334 citations indexed

About

Doreen Pachow is a scholar working on Neurology, Epidemiology and Molecular Biology. According to data from OpenAlex, Doreen Pachow has authored 11 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 7 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Doreen Pachow's work include Meningioma and schwannoma management (7 papers), Neurofibromatosis and Schwannoma Cases (6 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Doreen Pachow is often cited by papers focused on Meningioma and schwannoma management (7 papers), Neurofibromatosis and Schwannoma Cases (6 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Doreen Pachow collaborates with scholars based in Germany, United States and United Kingdom. Doreen Pachow's co-authors include Christian Mawrin, Elmar Kirches, Annette Wilisch-Neumann, Frank Angenstein, David H. Gutmann, Oliver Stork, Wolfgang Wick, Susanne Petri, Stefan Vielhaber and Gerburg Keilhoff and has published in prestigious journals such as Oncogene, Clinical Cancer Research and Neuroscience.

In The Last Decade

Doreen Pachow

11 papers receiving 329 citations

Peers

Doreen Pachow

EPIDE

NEURO

MB

GENET

CR

Annette Wilisch-Neumann Germany

Shihai Luan China

Patrícia H. Domingues Portugal

Tomasz Czernicki Poland

Donghai Wang China

Norichika Hashimoto Japan

Kadir Erkmen United States

Liqian Xie China

Kristen D. Hadfield United Kingdom

João N. Stávale Brazil

Annette Wilisch-Neumann Germany

Doreen Pachow

155 ×0.9

EPIDE

151 ×1.0

NEURO

137 ×1.2

MB

83 ×0.8

GENET

45 ×1.0

CR

Citations per year, relative to Doreen Pachow Doreen Pachow (= 1×) peers Annette Wilisch-Neumann

Countries citing papers authored by Doreen Pachow

Since Specialization

Citations

This map shows the geographic impact of Doreen Pachow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen Pachow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen Pachow more than expected).

Fields of papers citing papers by Doreen Pachow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen Pachow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen Pachow. The network helps show where Doreen Pachow may publish in the future.

Co-authorship network of co-authors of Doreen Pachow

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen Pachow. A scholar is included among the top collaborators of Doreen Pachow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen Pachow. Doreen Pachow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Kirches, Elmar, Doreen Pachow, Annette Wilisch-Neumann, et al.. (2018). The expression of the MSC-marker CD73 and of NF2/Merlin are correlated in meningiomas. Journal of Neuro-Oncology. 138(2). 251–259. 3 indexed citations

2.

Wilisch-Neumann, Annette, Doreen Pachow, Frank Angenstein, et al.. (2017). Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells. European Journal of Cancer. 73. 9–21. 28 indexed citations

3.

Pachow, Doreen, et al.. (2017). Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas. Journal of the Neurological Sciences. 380. 112–121. 26 indexed citations

4.

Cui, Yan, et al.. (2015). Deficiency of the protein-tyrosine phosphatase DEP-1/PTPRJ promotes matrix metalloproteinase-9 expression in meningioma cells. Journal of Neuro-Oncology. 122(3). 451–459. 5 indexed citations

5.

Wilisch-Neumann, Annette, et al.. (2014). Re-evaluation of cytostatic therapies for meningiomas in vitro. Journal of Cancer Research and Clinical Oncology. 140(8). 1343–1352. 14 indexed citations

6.

Wilisch-Neumann, Annette, Doreen Pachow, Elmar Kirches, & Christian Mawrin. (2014). MS-29 * SORAFENIB AND REGORAFENIB INHIBIT GROWTH AND MIGRATION OF MENINGIOMA CELLS. Neuro-Oncology. 16(suppl 5). v132–v132. 1 indexed citations

7.

Pachow, Doreen, et al.. (2014). The mTOR signaling pathway as a treatment target for intracranial neoplasms. Neuro-Oncology. 17(2). 189–199. 42 indexed citations

8.

Pachow, Doreen, Frank Angenstein, Oliver Stork, et al.. (2013). mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models. Clinical Cancer Research. 19(5). 1180–1189. 78 indexed citations

9.

Wilisch-Neumann, Annette, Doreen Pachow, Thomas Schneider, et al.. (2013). The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion. Clinical Cancer Research. 19(19). 5402–5412. 31 indexed citations

10.

Gobrecht, Philipp, Doreen Pachow, Annette Wilisch-Neumann, et al.. (2012). miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene. 32(39). 4712–4720. 56 indexed citations

11.

Kirches, Elmar, Annette Wilisch-Neumann, Doreen Pachow, et al.. (2012). Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience. 230. 94–101. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact